U.S. Vaccine Program Now Flush With Cash but Short on Key Details

A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance. Benjamin Mueller, Noah Weiland and Carl Zimmer | NYTimes Health | Disclosure